We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+7.47%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
AUM
$369M
AUM Growth
+$20.9M
Cap. Flow
-$1.4M
Cap. Flow %
-0.38%
Top 10 Hldgs %
25.11%
Holding
205
New
18
Increased
52
Reduced
73
Closed
13

Top Buys

Rank Stock Value
1
PSX icon
Phillips 66
PSX
+$6.79M
2
AVY icon
Avery Dennison
AVY
+$6.43M
3
LPX icon
Louisiana-Pacific
LPX
+$5.1M
4
INTC icon
Intel
INTC
+$4.19M
5
ZTS icon
Zoetis
ZTS
+$888K

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$6.53M
2
CELG
Celgene Corp
CELG
+$6.5M
3
LH icon
Labcorp
LH
+$5.56M
4
HQY icon
HealthEquity
HQY
+$5.07M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$805K

Sector Composition

Rank Sector Weight
1 Industrials 16.72%
2 Technology 16.16%
3 Financials 13.74%
4 Healthcare 12.21%
5 Communication Services 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG
201
DELISTED
Celgene Corp
CELG
-44,562
Closed -$6.5M

Similar funds

Dixon Hubard Feinour & Brown's Q4 2017 Portfolio in Review

As of Q4 2017, Dixon Hubard Feinour & Brown held 205 positions worth $369M, up 6% from $348M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Dixon Hubard Feinour & Brown's Q4 2017 filing shows 18 new, 52 increased, 73 reduced and 13 closed positions. Its largest new stake was Phillips 66: 71,419 shares worth $7.22M. The largest sale was Amgen, an estimated $6.53M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • Dixon Hubard Feinour & Brown's largest Q4 2017 buy was Phillips 66: 71,419 shares worth $7.22M.
  • Dixon Hubard Feinour & Brown added most to Intel in Q4 2017, an estimated $4.19M increase.
  • Dixon Hubard Feinour & Brown's biggest Q4 2017 reduction was Alphabet (Google) Class C, cutting an estimated $805K.
  • Dixon Hubard Feinour & Brown fully exited Amgen in Q4 2017, selling an estimated $6.53M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 25% of its $369M portfolio in Q4 2017.
  • Dixon Hubard Feinour & Brown opened 18 new positions and closed 13 in Q4 2017.
  • Dixon Hubard Feinour & Brown's portfolio value rose 6% quarter-over-quarter to $369M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q4 2017, filed 20 Feb 2018.